Cost effectiveness of intraoperative pathology in the management of indeterminate thyroid nodules
Arch. endocrinol. metab. (Online)
;
64(4): 356-361, July-Aug. 2020. tab, graf
Article
in English
| LILACS
| ID: biblio-1131102
ABSTRACT
ABSTRACT Objective This study aims to determine the cost effectiveness of rapid frozen section (RFS) for indeterminate thyroid nodules. Materials and methods A retrospective chart review was conducted between January 2009 and June 2013 at a tertiary care institution. Main outcomes were number needed to treat, RFS efficacy, and cost-savings of avoiding second completion thyroidectomy. Cost-effectiveness was estimated using 2015 Medicare reimbursement rate. Results Out of 1,114 patients undergoing thyroid surgery, 314 had preoperative AUS/FLUS cytopathology and subsequent thyroid lobectomy with RFS. RFS identified 13 of the 32 patients with malignancy resulting in a total thyroidectomy. 19 of the 29 malignancies not detected by RFS were papillary microcarcinomas. Conclusions Completion thyroidectomy was avoided in 1 out of every 24 patients resulting in cost-savings of $ 80.04 per patient. In the era of outpatient thyroid surgery, intraoperative RFS for indeterminate thyroid nodules is cost-effective.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Thyroid Nodule
Type of study:
Health economic evaluation
/
Observational study
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
Arch. endocrinol. metab. (Online)
Journal subject:
Endocrinology
/
Metabolism
Year:
2020
Type:
Article
Affiliation country:
United States
Institution/Affiliation country:
Loma Linda University Medical Center/US
/
University of Southern California/US
Similar
MEDLINE
...
LILACS
LIS